- €3.84bn
- €4.67bn
- €1.20bn
Brief: Diasorin Board Proposes Buyback Up To EUR 250 Mln
Europe Research Roundup: Beiersdorf, Neste, RS Group
Live Markets: Before the bell: futures steady, focus on Bayer, STOXX reshuffle
Fincantieri seen joining FTSE MIB as defence stocks surge, ousting Hera or DiaSorin
Deutsche Bank cuts Italy's DiaSorin to 'hold' on 'notable' growth slowdown
Live Markets: STOXX dips, Legrand weighs on AI plays, UK banks up
DiaSorin shares hit over 8-yr lows on Q3 miss, guidance cut
Europe Research Roundup: Applied Nutrition, Noba Bank Group, Trainline
Brief: Diasorin Q3 Net Profit EUR 38 Mln
Factors to watch on November 5
Europe's STOXX 600 closes higher, focus shifts to Nvidia results (updated)
Top of the Street: Deutsche Bank, Commerzbank, UniCredit
JPM starts DiaSorin at 'underweight' on limited scope for margin progress
Europe Research Roundup: Bioinvent, Diasorin, Sandoz
JPM starts bioMérieux at 'neutral', says growth prospects priced in
Morgan Stanley ups DiaSorin to 'overweight' on 'rare opportunity' valuation, shares rise
Europe Research Roundup: Barclays, Kingfisher, Tesco
Lottomatica seen joining Italy's blue chip stock index, ousting Diasorin or Pirelli
'Buying opportunity ahead of growth acceleration' - RBC raises DiaSorin to 'outperform'